Condition: Post Traumatic Stress Disorder (PTSD) · Sponsor: Tel Aviv University
This RCT investigates whether Cognitive Processing Therapy, a first line treatment for PTSD, can be enhanced by the use of the odor molecule Hexadecenal (HEX). HEX is secreted from body odor and has been shown to promotes psychological well-being and positive social interaction. For the active group Hex will be diffused in the treatment room during all treatment sessions. For the control group a vehicle placebo molecule will be diffused. Both therapists and patients will be blind to study condition.
This description comes directly from the study's public registry record.
Yair Bar Haim, PhD · 03-6405465 · yair1@tauex.tau.ac.il
Noga Zuk Barkan · +972-54-6147880 · nogabarkan2@gmail.com
Always discuss trial participation with your own doctor first.
| Tel Aviv University | Tel Aviv, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06968312